Biotech Venture Capital Endeavors

Biotech- venture capital, these two go hand in hand. The amazing advances in the field of biotechnology has made it possible for a number of entrepreneurs to start out on their own. Biotechnology is the future of medicine and no one knows that better than the entrepreneurs of today. Therefore they have made it a point to actively seek out their fortune in the biotech industry.

Biotechnology Offers

Now, as is the case with all forms of business, one needs investors to set up a thriving business. It is not possible for a single man or sometimes, even a single company to finance a business, especially in the field of biotechnology where all the equipment required is so expensive. For biotech, venture capital firms have many, many opportunities.

? Opportunities may be found in the fields of healthcare, medical instruments, life science and nutrition industries as well as medical information technologies.

? Why invest in the biotech industry? This is because the venture capital industry has seen a growth of about 50% in just twelve months!

? Biotechnology is a hot area to invest in because one can never tell when groundbreaking discoveries will be made, for the cure of killer diseases like cancer, HIV and even diabetes. In fact, even a successful therapy offers a great profit margin in these cases.

? One of the most rapidly growing areas of the global pharmaceutical business is the anti-infective drug area. This finds many, many takers.

Why Venture Capital?

But, in order to convince investors, especially in the field of biotechnology, entrepreneurs have to do some very hard persuading, they have to prove that their product actually works - through clinical trials, experiments etc. This is the hard part.

Is it any wonder that most privately owned biotechnology firms today, are dependent on the money which comes from venture capitals to fund their research and experiments? Of course, one comes across lucky firms which have entered into understandings or deals with large pharmas and thus can sustain their research, but as mentioned before, the money mainly comes from venture capitalists.

When you are starting out a biotech company, do remember to opt for venture funding because, the risk factor is a lot less for the entrepreneur. Investors put a lot at stake when they invest in new biotech companies because they are relatively unheard of and, since this industry is a very competitive one, one can never be too sure how long these new companies will survive.

Venture capital is a boon for most businesses, but especially so, if you have decided to step into the uncharted waters of the biotech industry. It is definitely an avenue that you must look to because, if your product is good, then you can easily achieve the high growth rates that form the necessary criterion for venture capital firms.

Who doesn't want path-breaking medical treatment? Plenty of people out there are willing to pay a whole lot for it too so when your forte is biotech, venture capital should be your means.

View the original article here

Capital Medical Venture - Whom To Approach For Funding

Capital medical venture or angel investor? Most entrepreneurs are confounded with this all-important question today. Who will invest money in their business or, more importantly which sort of investment should they approach? What would suit their business better?

Capital Medical Venture

A really good way of gauging this is by gauging your business venture. If you are confident of the ability of your business venture to provide good returns really soon, then go for venture capital firms. If you want to start large, then this is for you. These firms invest a whole lot of money, yes I'm talking big money here - their starting investment is five hundred thousand dollars and it goes into millions! But, they also charge a really high rate of interest - more than twenty percent per annum. Plus you need to give them quick returns, which generally is not a problem in the medicine field.

A capital medical venture is a venture which is quite challenging to finance because it is a type of venture which requires an extensive expertise of the industry and a very, very methodical form of planning. The good news is nowadays, venture capital firms are actively on the lookout for companies like manufacturers of diagnostics, radiation systems of the intracoronary kind and surgical instruments which are minimally invasive. So if you are starting out on a business in the medical field, a capital medical venture, then this is the best time to start.

There are groups of venture capitalists who are very generous indeed and are willing to provide an entrepreneur with two hundred million dollars on (hold your breath!) a single transaction. What is more they are willing to consider many different kinds of investment structures such as management buyouts, recapitalizations which are leveraged, minority equity positions as well. So they are willing to be flexible.

Whom To Choose?

Coming back to the main point. What are the differences between an angel investor and a venture capital firm?

An angel investor generally has his own private money which he is willing to invest in a business. But a venture capitalist gets their money from a collection or rather, a group of wealthy individuals. Thus there is a big difference in the motivations of these two kinds of investors and the reasons behind why they invest.

A venture capital firm's main motivation is to get good returns. Moreover, competition for their limited kind of funding is extremely keen. Many firms fund only about five companies out of say, every thousand business proposals they view per year so they are extremely cautious.

Angel investors have, on the other hand, experience in building a company. Sometimes, it gives them a high to invest in new startups and that is their sole reason for investment. Sometimes an idea catches their fancy and they invest for the heck of it.

A capital medical venture is often a risky business, so opting for an gel investor in this case is the best course of action for a new entrepreneur.

View the original article here